Compare Marqeta Inc (MQ) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marqeta Inc vs Regeneron Pharmaceuticals Inc — how do they compare? Marqeta Inc trades at $17.22 (market cap $1.85B), while Regeneron Pharmaceuticals Inc trades at $670 (market cap $70.47B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 38.1× Marqeta Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.56% dividend while Marqeta Inc pays none. Which is the better fit depends on your goals.
| MQ | REGN | |
|---|---|---|
Market Cap | $1.85B | $70.47B |
Sector | Technology | Health |
52-Week High | $27.32 | $812.27 |
52-Week Low | $15.04 | $545.46 |
Enterprise Value | $1.15B | $64.42B |
Dividend Yield | — | 0.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Marqeta Inc
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
Read more on MQ →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
